Document No.3 -
Package Insert Warnings 1971
So, having
read what goes before, we now know that Glaxo, in whichever
guise are saying the same, thing, "We warned everybody
about the dangers of Arachnoiditis on the 1971 Package Inserts".
Here we
publish the relevant sections of those Package Inserts which
form their defence against culpability. Please note the
differences before moving on to our final document in this
series. I would also like to bring to your attention that
these package inserts were clearly marked: "For the
medical profession."
The patient
therefore was most unlikely to have access to them. So who
is repsonsible for the patient being deprived of their right
to "informed consent"? Both of our examples contain
some medical vocabulary which the general public does not
have to deal with. Here is our short glossary of terms which
you should read before proceeding:-
Aspirate
A procedure to remove fluids from the body using a syringe.
Cerebrospinal
Fluid
A clear, colourless fluid which contains small quantities
of glucose and protein, it bathes the brain and the spinal
cord.
Contrast
Medium
A substance that is introduced, using a syringe and catheter,
in this case, into the sub-arachnoid space, and, because
of the difference in abosorption of x-rays, ensures that
doctors can see that structure in greater detail than would
be the case without it.
Lumbar
puncture
A dianostic procedure where a sterile needle is introduced
into the lower spine to collect cerebrospinal fluid for
diagnostic purposes.
Lumbo-sacral
Lower part of the back from just below the ribs to the sacral,
or tail bone, structure.
Iophendylate
This is the chemical name of both Myodil and Pantopaque.
Supplied to Glaxo, through the British Drug House, this
substance was merely sterilised and bottled before being
shipped out as Myodil.
Photophobia
Abnormal intolerance to light.
Pyrexia
A fever type reaction which causes high temperatures.
Sciatica
Pain radiating from the back into the buttock and down into
the legs.
Subarachnoid
space
The space between the arachnoid layer of the spinal cord
and, the interior layer, the pia mater, which encloses,
and protects, the spinal nerves.
Top
Package Insert Warnings
- February 1971
After Effects
These are only slightly greater than after simple lumbar
puncture. Some workers aspirate as much Myodil as possible
after radiological examination has been completed. Other
radiologists leave the contrast medium in situ and it is
stated that no harm ensues. The material often tracks down
the nerves sheaths in the lumbo-sacral region, or remains
in the lumbo-sacral sub-arachnoid space. It is slowly absorbed,
about fifty per cent disappearing after a year.
Contra-indications
As for simple lumbar puncture. The examination should not
be made within 14 days of a previous lumbar puncture.
Package Insert Warnings
- August 1971
Contra-indications
As for simple lumbar puncture.
Warnings
In the presence of blood in the cerebrospinal fluid (arising
either as a result of lumbar puncture of the original disease)
myelography with Myodil may cause sever after-effects. Under
these circumstances the examination should be postponed.
If Myodil enter the blood stream, it can cause shock and
violent coughing.
Ideally, all glass syringes
should be used, as Myodil may dissolve out toxic substances
from some plastic syringes and/or their rubber plungers.
If a plastic syringe is employed, the Myodil should be drawn
into it immediately prior to injection to minimise contact
with the syringe.
Precautions
If possible, ten to fourteen days should elapse between
lumbar puncture and subsequent myelography.
Many workers remove as
much Myodil as possible after myelography in the belief
that this reduces unpleasant after-effects. However, when
only moderate amounts of the medium are involved, some consider
it better not to aspirate if this requires another lumbar
puncture.
Adverse Reactions
Provided a suitalble technique of injection is used, preferably
with television control, serious after-effects are rare.
As with simple lumbar puncture, headache is frequent, and
after myelography it is sometime severe, with vomiting and
photophobia. Pyrexia and stiff neck can occur, usually soon
after myelography; rarely, they appear some weeks after
the examination. Symptoms normally resolve within several
days. Some patients react to myelography with low back pain,
an previous symptoms such as sciatica may be exacerbated.
Occasionally arachnoiditis
has been reported, but that type of reaction has not been
associated with a specific disease or technique of investigation.
The literature contains references to adhesions and fibrous
exudate being found on operation in patients who had at
some time undergone myelography with iophendylate. The sporadic
nature of these reports, and sometimes the sparseness of
information about the patient's condition prior to myelography,
make it difficult to evaluate the role of Iophendylate.
However, these reports probably add weight to the case for
removing as much Myodil as possible at the time of investigation.
Top
Back
to Government and Business Papers